Axogen, Inc. — Director's Dealing 2018

Aug 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-08-14

Reporting Person: Wendell Amy McBride (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-14	Common Stock	P	5000	$36.89	Acquired	18333	Direct

Footnotes

F1: The reporting person purchased these shares in her individual capacity in the open market and not through any directed share or other formal program.

F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $36.85 to $36.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.